SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-23-000130
Filing Date
2023-07-18
Accepted
2023-07-18 18:22:14
Documents
4
Period of Report
2023-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1689718924.html 3  
1 FORM 3 wk-form3_1689718924.xml 3 2247
2 EX-24.1 millerpoasigned2023.htm EX-24.1 923
3 millerpoasigned2023001.jpg GRAPHIC 257966
4 millerpoasigned2023002.jpg GRAPHIC 121652
  Complete submission text file 0001367644-23-000130.txt   527552
Mailing Address EMERGENT BIOSOLUTIONS INC. 400 PROFESSIONAL DR. STE. 400 GAITHERSBURG MD 20879
Business Address
MILLER H HAYWOOD III (Reporting) CIK: 0001060278 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 231095233

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations